plushcare glp-1 Medications in Employer Healthcare Plans | Dr. James Wantuck, Accolade & plushcare glp 1 Meet PlushCare–

There are GLP-1 receptor agonists available that are approved to treat either type 2 diabetes or obesity along with diet and exercise

Short-acting agents like exenatide often cause more gastroparesis (slow gastric emptying), while long-acting ones like dulaglutide may be better tolerated

Osmotic laxatives such as macrogol (polyethylene glycol) are often considered first-line for chronic constipation on GLP-1 therapy, as they draw water into the bowel to soften stools

Clinical trial data cited is from brand-name medication studies and represents population averages, not individual guarantees

GLP-1 inhibitors are injectable medications originally developed to treat type 2 diabetes